Novatoris launches smartphone-based research into multiple sclerosis

By Laura Mullan
Novatoruis is partnering with Sage Bionetworks to launch a large-scale multiple sclerosis study using data from smartphones. The study, dubbed elevateM...

Novatoruis is partnering with Sage Bionetworks to launch a large-scale multiple sclerosis study using data from smartphones.

The study, dubbed elevateMS, hopes to evaluate, in real time, the daily struggles faced by people living with MS.

The study will use an app to collect information about patient’s movement performance and symptoms from their smartphones.

RELATED STORIES:

It is hoped that the results may help researchers develop new ways to measure treatment’s effectiveness.

Designed with input from patients, neurologists and disease advocates, the study’s mobile app was built on the Apple ResearchKit platform.

Beneficially, the mobile format eliminates the need for clinic visits which broadens the population that can participate. It’s an outcome that is already pushing some oncology companies to search for digital solutions of their own as fewer potential trial participants emerge.

In a statement, Dr Stanley Cohan, medical director of the Providence Multiple Sclerosis Centre in Oregon said: “As physicians, we always want to know how our patients with MS are doing on the treatments we prescribe.

“With the elevateMS app, study participants can frequently document their symptoms in a personal health story.

“In turn, this data may provide researchers with new ways to look at disease progression and treatment effectiveness.”

The study is entitled “Evaluation of Evidence from Smart Phone Sensors and Patient-Reported Outcomes in Participants with Multiple Sclerosis (elevateMS)

Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals